Perrigo Stock Forecast
NYSE: PRGOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 8, 10:18 AM ET
PRGO analyst consensus
Consensus (5 analysts)
none
Avg. price target
$16.50+15.42%
- Strong buy 1
- Buy 1
- Hold 3
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 5 Wall Street analysts covering Perrigo (2026-10-07), 2 rate the stock a buy or strong buy, 3 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "none". The average 12-month price target is $16.50, with a high estimate of $20.00 and a low estimate of $14.00. The average target implies upside of 15.4% from the current price of $14.30.
The spread between the highest and lowest targets is 42.9%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for PRGO.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 1 | 20% |
| Buy | 1 | 20% |
| Hold | 3 | 60% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $14.00 | -2.06% |
| Average target | $16.50 | +15.42% |
| High target | $20.00 | +39.91% |